Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-21

FDA Approved: PROCTOFOAM HC — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for PROCTOFOAM HC (pramoxine hydrochloride and hydrocortisone acetate) from Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCTOFOAM HC (Pramoxine hydrochloride, hydrocortisone acetate)

Snippet

SUPPL AP for PROCTOFOAM HC (PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE)